Bartiromo: Novartis CEO upbeat on company, health care USA TODAY The toughest actually has been lung cancer, partly because it's a very complex cancer, and it's really not just one cancer; there are many different mutations that cause lung cancer. At Novartis, we have a new drug that is in early development for non ... |
